Advertisement
Regulations
Subscribe to Regulations

The Lead

Arizona Monitoring Hundreds for Measles Linked to Disneyland

January 29, 2015 10:03 am | by Felicia Fonseca, Associated Press | News | Comments

A measles outbreak in Arizona that originated at California's Disney parks is at risk of increasing dramatically in size as health officials keep tabs on 1,000 people, including nearly 200 children who could have been exposed at a Phoenix-area medical center.

U.S. Measles Outbreak Hits 87 Cases and Counting

January 28, 2015 12:33 pm | by Stephanie Guzowski, Editor | Articles | Comments

The measles outbreak, which originated at Disneyland, continues to expand, with 87...

Mylan Expands Hepatitis C Licensing Agreement with Gilead

January 26, 2015 11:18 am | by Associated Press | News | Comments

 Mylan Inc. announced that its subsidiary Mylan Laboratories Limited is expanding...

Added Protections for Consumer Info on Health Website

January 26, 2015 9:56 am | by Associated Press | News | Comments

The Obama administration appears to be making broader changes to protect consumer information on...

View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

Medical Pot Only OK for Sick Kids Failed by Other Drugs: MDS

January 26, 2015 9:52 am | by Lindsey Tanner, AP Medical Writer - Associated Press | News | Comments

With virtually no hard proof that medical marijuana benefits sick children, and evidence that it may harm developing brains, the drug should only be used for severely ill kids who have no other treatment option, the nation's most influential pediatricians group says in a new policy. Read more...

Aetna Picks Gilead Sciences Hepatitis C Drugs Over Abbvie's

January 20, 2015 12:01 pm | by Associated Press | News | Comments

Insurer Aetna has made new hepatitis C drugs from Gilead Sciences Inc. preferred treatments for customers with the liver-destroying virus. Read more...                                    

Container Closure Integrity: Testing at Low Temps

January 20, 2015 11:10 am | by Louis Brasten, Supervisor, Routine and Functional Analysis/Filling Services, Barbara Jacobs, Scientist, Analytical Services, Alicia Brydzinski, Scientist, Analytical Services - West Pharmaceutical Services, Inc. | Articles | Comments

The container closure integrity, or CCI, on packaging for parenteral drug products plays a critical role in the preservation of the drug product. The combination of the packaging closure components must be carefully selected to eliminate means of contamination that could affect the drug product negatively. Read more...

Advertisement

To Screen or Not to Screen for Hepatitis C

January 15, 2015 10:44 am | by Stanford Medicine | News | Comments

In the past few years, newer, more effective treatments have been introduced for hepatitis C – a disease that can lead to chronic liver problems and in the worst cases, liver cancer. Read more...                       

U.S. Painkiller Abuse 'Epidemic' May Be Declining: Study

January 15, 2015 10:35 am | News | Comments

The U.S. "epidemic" of prescription-painkiller abuse may be starting to reverse course, a new study suggests. Experts said the findings, published in the New England Journal of Medicine, are welcome news. The decline suggests that recent laws and prescribing guidelines aimed at preventing painkiller abuse are working to some degree. Read more...

'Molecular Truck' Could Deliver New Treatment

January 15, 2015 10:20 am | by Darci Slaten, University of Arizona | News | Comments

University of Arizona researchers have developed a novel drug and delivery system to treat inflammation and ulcerations in the colon. Read more...                                            

In the News: Open Access Journals

January 13, 2015 8:55 am | by Drug Discovery & Development Staff | Articles | Comments

A number of open access journals have made the news recently. The preprint open access archive, arXiv.org, run by Cornell University, is often used by scientists, from physicists to quantitative biologists, to get their ideas out there quickly and stake out their intellectual ground, before they enter the slow process of peer review. Read more...

$18M Seized From Massachusetts Compounding Pharmacy Accounts

January 7, 2015 11:10 am | by Associated Press | News | Comments

Authorities have seized over $18 million from the owners of a Massachusetts compounding pharmacy at the center of a 2012 meningitis outbreak that killed 64 people nationwide.                       

Advertisement

FDA to Ease Ban on Blood Donations by Gay Men

December 24, 2014 8:49 am | by Matthew Perrone, AP Health Writer | News | Comments

Federal officials have moved closer to overturning a decades-old ban on blood donations from gay and bisexual men, but activists say the proposed alternative would continue to stigmatize men who have sex with men.  

High Vancomycin Doses Fuel Risk of Kidney Damage in Children

December 22, 2014 3:01 pm | by Johns Hopkins University | News | Comments

A new study shows that hospitalized children given high-dose IV infusions of the antibiotic vancomycin to treat drug-resistant bacterial infections face an increased risk for kidney damage. Read more...          

Ohio House to Consider Lethal Injection Drug Bill

December 17, 2014 12:22 pm | News | Comments

The names of companies that provide Ohio with lethal injection drugs would be shielded under a proposal the state House is poised to vote on Wednesday. Read more...                                        

Teen Prescription Opioid Abuse Trend Down

December 16, 2014 11:27 am | by NIH | News | Comments

Use of cigarettes, alcohol, and abuse of prescription pain relievers among teens has declined since 2013 while marijuana use rates were stable, according to the 2014 Monitoring the Future (MTF) survey, released today by the National Institute on Drug Abuse (NIDA). However, use of e-cigarettes, measured in the report for the first time, is high. Read more...

Judge Halts Alzheimer's Drug Swap Until July

December 16, 2014 10:49 am | by Associated Press | News | Comments

A federal judge on Monday ordered an Irish drug manufacturer to halt its plans to discontinue its widely used Alzheimer's medication, allegedly in an effort to drive patients to a newer patented drug. Read more...                                                  

Advertisement

J&J Collaborates with Janssen,USAID to Expand Access to MDR-TB Compound

December 12, 2014 11:15 am | News | Comments

Johnson & Johnson today announced that its affiliate Janssen Therapeutics, Division of Janssen Products, LP (Janssen), has signed a Memorandum of Understanding (MOU) representing the intention of the Company along with the United States Agency for International Development (USAID) to step up the fight against the health threat of antibiotic-resistant bacteria. Read more...

CA Battles Whooping Cough Epidemic

December 12, 2014 11:07 am | News | Comments

California officials are battling the worst whooping cough epidemic to hit the state in seven decades as a recent rebound in cases raises questions about the effectiveness of the pertussis vaccine. Read more...                    

Ohio Lawmakers Debate Execution Drugmaker Bill

December 10, 2014 1:01 pm | by Andrew Welsch-Huggins, AP Legal Affairs Writer - Associated Press | News | Comments

Companies providing Ohio with lethal injection drugs would have their names shielded for at least 20 years, under a bill scheduled for a possible vote that lawmakers say is needed to restart executions in the state. Read more...                                  

Royalty Pharma Pays $3.3B for Cystic Fibrosis Royalties

November 19, 2014 1:51 pm | News | Comments

Royalty Pharma announced its acquisition of royalties on Vertex Pharmaceuticals' cystic fibrosis treatments owned by Cystic Fibrosis Foundation Therapeutics' ("CFFT"), an affiliate of the Cystic Fibrosis Foundation, for a cash payment of $3.3 billion. Read more...

Mali On High Alert With New Ebola Cluster

November 17, 2014 9:19 am | by Baba Ahmed - Associated Press | News | Comments

 Mali had been spared the virus now blamed for killing more than 5,000 people across West Africa but now there are least three confirmed Ebola deaths. Read more...                

Using Real-World Data for Outcomes Research and Comparative Effectiveness Studies

November 4, 2014 10:17 am | by Christina Mack, Ph.D., MSPH, Associate Director, Epidemiology, Real-World & Late Phase Research, Quintiles, and Kathy Lang, Ph.D., Senior Director, Emerging Businesses Data & Analytics, Real-World & Late Phase Research, Quintiles | Articles | Comments

Biopharma is increasingly harnessing the power of data collected outside of a controlled clinical environment to generate valuable insights to support products throughout their lifecycle. Read more...

BDSI's Opioid Dependence Treatment Now Available in U.S.

November 3, 2014 1:23 pm | News | Comments

BioDelivery Sciences International, Inc.announced that Bunavail (buprenorphine and naloxone) buccal film (CIII) is now commercially available. Read more...                                               

Actavis, Durata Therapeutics Get FTC Clearance

November 3, 2014 1:08 pm | News | Comments

Actavis plc and Durata Therapeutics, Inc. announced that the U.S. Federal Trade Commission (FTC) has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR") with respect to Actavis' pending acquisition of Durata. Read more...

Biosimilar Medications Could Create Billions in Savings

November 3, 2014 12:59 pm | News | Comments

Introducing competing “biosimilar” versions of complex biologic drugs used to treat illnesses such as cancer and rheumatoid arthritis could cut spending on biologics in the United States by $44 billion over the next decade, according to new analysis from the RAND Corporation. Read more...

Regulatory Data: Vital for DDI Risk-Mitigation Efforts

November 3, 2014 11:04 am | by Philip MacLaughlin, Product Director, PharmaPendium, Elsevier | Articles | Comments

Unanticipated adverse drug-drug interactions (DDIs) have led to the withdrawal of several high-profile drugs that had been available for a number of years, including terfenadine, astemizole, cisapride, grepafloxacin and mibefradil.  Read more... 

Daiichi Sankyo's Heart Drug Gets FDA Recommendation

October 31, 2014 10:11 am | News | Comments

Daiichi Sankyo announced that the FDA Cardiovascular and Renal Drugs Advisory Committee voted 9 to 1 to recommend approval of once-daily Savaysa (edoxaban) 60 mg dosing regimen for the reduction in risk of stroke and systemic embolic events (SEE) in patients with non-valvular atrial fibrillation (NVAF). Read more...

Boehringer Ingelheim, Lilly Restructure Diabetes Alliance

October 29, 2014 10:01 am | News | Comments

In a move that will strengthen their alliance by enhancing efficiencies and enabling greater focus on product launches, Boehringer Ingelheim and Eli Lilly and Company are changing the operational and financial structure of their diabetes alliance in certain countries. Read more...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading